Two Sigma Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,900
Closed -$610K 4597
2021
Q4
$610K Buy
10,900
+3,200
+42% +$196K ﹤0.01% 3044
2021
Q3
$501K Sell
7,700
-3,900
-34% -$266K ﹤0.01% 3263
2021
Q2
$736K Sell
11,600
-5,500
-32% -$325K ﹤0.01% 2760
2021
Q1
$1.02M Buy
+17,100
New +$930K ﹤0.01% 2291

Other funds holding AXNX

Two Sigma Investments's AXNX Position: Q2 2023 in Review

Two Sigma Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 81,605 shares — an estimated $4.45M sold.

Two Sigma Investments first reported a position in AXNX in Q3 2019 and held it in 8 quarters. The position peaked at $9.8M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Two Sigma Investments reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 81,605 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $4.45M.
  • Two Sigma Investments first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
  • Two Sigma Investments's Axonics, Inc. Common Stock position peaked at $9.8M in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.